Dermata Therapeutics Inc (DRMA) is a Healthcare · Biotechnology company listed on NASDAQ. Price $1.16 (+0.00%), Market cap $0.00B, 52-week low–high $0.58 ~ $7.06.
Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Financial statements, price targets, institutional (13F) holdings and related news for Dermata Therapeutics Inc are updated in real time on BlackAll Trade.
Dermata Therapeutics Inc trades at $1.16 (+0.00%). Real-time quotes and charts are available on BlackAll Trade.
Dermata Therapeutics Inc has a market cap of about $0.00B.
Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer ski